BCEL
Congressional Trades
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Christopher L. JacobsHouse · R · NY |
BCELBCEL · Stock |
Sale $1,001 - $15,000 |
Dec 12, 2022 | Nov 8, 2022 | Filing ↗ |
Christopher L. JacobsHouse · R · NY |
BCELBCEL · Stock |
Purchase $15,001 - $50,000 |
Jul 28, 2022 | Jun 16, 2022 | Filing ↗ |
Whale Activity
No 13F positions in BCEL among the institutional filers we track.
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Orwin John APRESIDENT & CEO · Director | Purchase | +1 | n/c | — | Apr 11, 2024 | Form 4 ↗ |
| Serafini TitoDirector | Sale | −20.8K | $0.07 | $1K | Apr 1, 2024 | Form 4 ↗ |
| BAKER JULIAN | Sale | −251.9K | $0.40 | $101K | Oct 19, 2023 | Form 4 ↗ |
| BAKER JULIAN | Sale | −22.8K | $0.40 | $9K | Oct 19, 2023 | Form 4 ↗ |
| Orwin John APRESIDENT & CEO · Director | Sale | −23.0K | $0.37 | $8K | Sep 1, 2023 | Form 4 ↗ |
| Serafini TitoDirector | Sale | −8,393 | $0.37 | $3K | Sep 1, 2023 | Form 4 ↗ |
| Courtney PhillipsGENERAL COUNSEL & SECRETARY | Sale | −7,061 | $0.37 | $3K | Sep 1, 2023 | Form 4 ↗ |
| Serafini TitoChief Strategy Officer · Director | Sale | −5,487 | $0.95 | $5K | Aug 2, 2023 | Form 4 ↗ |
| CROSS HERBChief Financial Officer | Sale | −5,487 | $0.95 | $5K | Aug 2, 2023 | Form 4 ↗ |
| Gould Stephen EChief Scientific Officer | Sale | −4,076 | $0.95 | $4K | Aug 2, 2023 | Form 4 ↗ |
| Courtney PhillipsGeneral Counsel & Secretary | Sale | −4,076 | $0.95 | $4K | Aug 2, 2023 | Form 4 ↗ |
| CROSS HERBChief Financial Officer | Grant / award | +43.8K | $0.00 | $0 | Feb 9, 2023 | Form 4 ↗ |
| Serafini TitoChief Strategy Officer · Director | Grant / award | −43.8K | $0.00 | $0 | Feb 9, 2023 | Form 4 ↗ |
| Courtney PhillipsGeneral Counsel & Secretary | Grant / award | +32.5K | $0.00 | $0 | Feb 9, 2023 | Form 4 ↗ |
| Gould Stephen EChief Scientific Officer | Grant / award | +32.5K | $0.00 | $0 | Feb 9, 2023 | Form 4 ↗ |
| Serafini TitoChief Strategy Officer · Director | Sale | −7,646 | $1.78 | $14K | Sep 2, 2022 | Form 4 ↗ |
| Orwin John APresident & CEO · Director | Sale | −20.9K | $1.78 | $37K | Sep 2, 2022 | Form 4 ↗ |
| CROSS HERBChief Financial Officer | Sale | −7,646 | $1.78 | $14K | Sep 2, 2022 | Form 4 ↗ |
| Courtney PhillipsGeneral Counsel & Secretary | Sale | −6,432 | $1.78 | $11K | Sep 2, 2022 | Form 4 ↗ |
| Serafini TitoChief Strategy Officer · Director | Sale | −15.0K | $2.02 | $30K | Jun 28, 2022 | Form 4 ↗ |
Fund Holders
Funds report their holdings by CUSIP, and BCEL could not be matched to one, so no fund holdings are shown.
Activist & Passive Stakes
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
No lobbying filings found naming BCEL as the client.
Government Contracts
No federal contract awards found for BCEL.
U.S. Patents
No USPTO patent applications found for BCEL.
Annual Financials
No annual XBRL figures on record for BCEL. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
No price history on record for BCEL.
Material Events (8-K)
No 8-K filings on record.
About BCEL
No company profile on record.

